scispace - formally typeset
R

Robert Fagard

Researcher at Katholieke Universiteit Leuven

Publications -  788
Citations -  109235

Robert Fagard is an academic researcher from Katholieke Universiteit Leuven. The author has contributed to research in topics: Blood pressure & Ambulatory blood pressure. The author has an hindex of 114, co-authored 787 publications receiving 104613 citations.

Papers
More filters
Journal ArticleDOI

Association between hypertension and variation in the α- and β-adducin genes in a white population

TL;DR: It is hypothesized that inhibition of the renin-aldosterone system in men and absence of such a compensatory mechanism in women may explain, at least to some extent, the sexual dimorphism of the blood pressure phenotype in relation to the C1797T β-adducin polymorphism.
Journal ArticleDOI

Host and environmental determinants of heart rate and heart rate variability in four European populations.

TL;DR: In this paper, the authors investigated the association between heart rate and its variability (HRV), and gender, age, posture, breathing frequency, body mass index, systolic blood pressure, family history of hypertension and various lifestyle factors, such as smoking, alcohol and coffee consumption and physical activity.
Journal ArticleDOI

Transforming growth factor-β1 induces angiotensin-converting enzyme synthesis in rat cardiac fibroblasts during their differentiation to myofibroblasts

TL;DR: TGF-β 1 is able to induce the appearance of ACE in cultures of adult rat cardiac ventricular fibroblasts and this induction was accompanied by a profound modification of the fibro Blasts phenotype, which consisted of a change in cell morphology, an enlargement of cell volume and an increase in cell protein content.
Journal ArticleDOI

Cardiovascular risk in white-coat and sustained hypertensive patients.

TL;DR: In this paper, the authors compared cardiovascular outcome between patients with white-coat and sustained hypertension who had previously participated in the Ambulatory Blood Pressure Monitoring and Treatment of Hypertension (APTH) trial.